Search results - 3 results

COVID-19 vaccine effectiveness against symptomatic infection and hospitalisation in Belgium, July 2021 to May 2022.

used a test-negative design and proportional hazard regression to estimate VE i and VE h, controlling for prior infection, time since vaccination, age, sex, residence and calendar week of ...

Controlled Human Infection Studies: Proposals for guidance on how to design, develop and produce a challenge strain.

Pieter Source: Biologicals, Volume 74 (2021) Abstract: There is an increasing need to establish quality principles for designing, developing and manufacturing challenge agents as currently these agents are ...

Panel discussion on quality by design

PDA Europe, Issue PDA Europe, Berlin, Germany (2015) Keywords: challenge CHALLENGES conference Countries Design developing Developing Countries Discussion Europe ON Quality vaccine vaccines WHO Health ...

QR code

QR code for this page URL